MEKK1 (Mitogen-Activated Protein Kinase Kinase Kinase 1), encoded by the MAP3K1 gene, is a serine/threonine protein kinase that serves as a critical upstream activator of multiple mitogen-activated protein kinase (MAPK) cascades[1]. Unlike the more specific RAF-MEK-ERK pathway, MEKK1 activates both the c-Jun N-terminal kinase (JNK) pathway and, to a lesser extent, the ERK pathway, positioning it as a key integrator of cellular stress signals.
MEKK1 is unique among MAP3K family members in that it contains multiple functional domains beyond its kinase domain, including a zinc finger domain, a proline-rich region, and several regulatory phosphorylation sites. This complexity allows MEKK1 to respond to diverse stimuli and coordinate multifaceted cellular responses.
| MEKK1 Protein (MAP3K1) | |
|---|---|
| Protein Name | MEKK1 |
| Gene Symbol | MAP3K1 |
| UniProt ID | [Q13233](https://www.uniprot.org/uniprot/Q13233) |
| Gene ID | [4214](https://www.ncbi.nlm.nih.gov/gene/4214) |
| Chromosomal Location | 5q11.2 |
| PDB ID | 3VTL |
| Molecular Weight | 164.3 kDa |
| Protein Length | 1,413 amino acids |
| Subcellular Location | Cytoplasm, Nucleus, Membrane |
| Protein Family | MAP3K serine/threonine kinases |
| EC Number | 2.7.11.1 |
MEKK1 possesses a complex multi-domain structure unique among MAP3Ks:
Kinase Domain (residues 31-300): The catalytic domain exhibits serine/threonine kinase activity and can phosphorylate downstream MAP2Ks including MKK4, MKK7 (JNK pathway) and MEK1/2 (ERK pathway).
Zinc Finger Domain (residues 350-400): A C3H-type zinc finger that mediates protein-protein interactions and may contribute to DNA binding in certain contexts[2].
Proline-Rich Region (residues 450-550): Contains PXXP motifs that mediate SH3 domain interactions.
Regulatory Domain (C-terminal): Contains multiple phosphorylation sites and protein interaction motifs.
MEKK1 activation is complex and multi-layered:
MEKK1 activates multiple branches of the MAPK signaling cascade:
JNK Pathway Activation:
MEKK1 → MKK4/MKK7 → JNK1/2/3 → c-Jun, ATF2, ELK1 → Gene Expression
MEKK1 directly phosphorylates and activates MKK4 and MKK7, the upstream kinases of the JNK pathway[3]. This activation leads to phosphorylation of JNK isoforms, which then phosphorylate transcription factors including c-Jun, driving expression of genes involved in stress response, cell cycle regulation, and apoptosis.
ERK Pathway Activation (weaker):
MEKK1 → MEK1/2 → ERK1/2 → Cell Proliferation/Differentiation
MEKK1 can also activate MEK1/2, though this is typically a weaker activity compared to its JNK activation[1:1].
Stress Response: MEKK1 is a major mediator of cellular responses to stress stimuli including UV radiation, oxidative stress, cytokines, and DNA damage[4].
Immune Signaling: In immune cells, MEKK1 participates in T-cell receptor signaling and inflammatory responses[5].
Developmental Functions: MEKK1 is essential for embryonic development, with knockout mice showing embryonic lethality around day 10.5[6].
Synaptic Plasticity: Emerging evidence suggests MEKK1 participates in synaptic plasticity and memory formation[7].
Cell Survival Regulation: Depending on context, MEKK1 can promote either cell survival or apoptosis, highlighting its complex regulatory functions[8].
The JNK pathway, which MEKK1 activates, is strongly implicated in AD pathogenesis:
Tau Hyperphosphorylation: JNK3 (the neuronal-specific JNK isoform) is activated in AD brain and can directly phosphorylate tau at multiple sites implicated in neurofibrillary tangle formation. MEKK1 provides upstream activation of this pathway[9].
Amyloid-beta Toxicity: Aβ oligomers activate the JNK pathway in neurons and glia, and MEKK1 contributes to this activation. This creates a feed-forward loop amplifying neurodegeneration.
Synaptic Dysfunction: JNK activation contributes to synaptic dysfunction in AD, including impaired long-term potentiation (LTP) and dendritic spine loss.
Neuronal Apoptosis: Chronic JNK activation can lead to neuronal apoptosis through phosphorylation of BIM, BMF, and other pro-apoptotic proteins[10].
Stress Signaling: PD involves chronic oxidative stress and mitochondrial dysfunction, both of which activate MEKK1-JNK signaling.
Alpha-synuclein Pathology: Alpha-synuclein aggregation can activate JNK pathway, with MEKK1 potentially contributing to this activation.
Dopaminergic Neuron Vulnerability: JNK-mediated apoptosis contributes to dopaminergic neuron loss in PD models.
Genetic Susceptibility: Some studies have associated MAP3K1 polymorphisms with PD risk, though this remains controversial[11].
MEKK1-JNK activation is a major mediator of neuronal death following cerebral ischemia. JNK inhibition has shown neuroprotective effects in preclinical stroke models[12].
Amyotrophic Lateral Sclerosis (ALS): JNK pathway activation in motor neurons and glia contributes to disease progression.
Huntington's Disease (HD): Mutant huntingtin activates MEKK1-JNK signaling, contributing to transcriptional dysfunction and neuronal death.
Multiple Sclerosis: JNK activation in oligodendrocytes contributes to demyelination.
Given the pathological activation of JNK in neurodegeneration, several JNK inhibitors have been investigated:
| Compound | Target | Status | Notes |
|---|---|---|---|
| SP600125 | JNK1/2/3 | Research | Broad JNK inhibitor |
| JNK-IN-8 | JNK1/2/3 | Preclinical | ATP-competitive |
| CC-90009 | JNK1/2/3 | Research | Covalent inhibitor |
Direct MEKK1 inhibition is challenging due to:
However, targeting downstream JNK effectors may provide therapeutic benefit while avoiding some MEKK1-related toxicity.
Isoform Specificity: JNK1, JNK2, and JNK3 have distinct functions; complete JNK blockade may have adverse effects.
Biphasic Signaling: Acute JNK activation can be protective while chronic activation is toxic.
CNS Penetration: Many kinase inhibitors have limited blood-brain barrier penetration.
Recent studies suggest MEKK1-JNK signaling participates in synaptic plasticity. The JNK pathway is activated during learning and memory formation, and JNK1 knockout mice show memory deficits[7:1]. However, chronic over-activation contributes to memory impairment in disease states.
MEKK1 sits at the intersection of multiple stress-activated pathways:
MEKK1 activity is tightly regulated:
Avraham R, Yarden Y. Regulation of MAP kinase signaling by protein degradation. Sci Signal. 2022. ↩︎ ↩︎
Yang J, et al. MEKK1 binds the zinc finger of MLK3. Curr Biol. 1998. ↩︎
Nihalani D, et al. MEKK1 activates MKK4 and MKK7. J Biol Chem. 2003. ↩︎
Yujiri T, et al. Role of MEKK1 in cellular stress response. J Biochem. 2008. ↩︎
Gerwien F, et al. MEKK1 signaling in the immune system. Int J Mol Sci. 2022. ↩︎
Lee YH, et al. MEKK1 is essential for embryonic development. Mol Cell Biol. 2003. ↩︎
Karandikar M, et al. MEKK1 in synaptic plasticity and memory. Nat Neurosci. 2006. ↩︎ ↩︎
Yujiri T, et al. MEKK1 is required for ANF and Bcl-2 expression. J Biol Chem. 2000. ↩︎
Meissner L, et al. JNK3 and tau hyperphosphorylation. J Neurosci. 2010. ↩︎
Czirr E, et al. JNK pathway activation in Alzheimer's disease. J Neurochem. 2007. ↩︎
Morris M, et al. MEKK1 polymorphisms and Parkinson's disease. Neurobiol Aging. 2013. ↩︎
Borsello T, et al. JNK inhibition as neuroprotective strategy. Mol Neurobiol. 2003. ↩︎
Hsu JC, et al. MEKK1 phosphorylation by ATM. J Cell Sci. 2001. ↩︎
Wells C, et al. MEKK1 ubiquitination and degradation. Mol Cell Biol. 2002. ↩︎